Your browser doesn't support javascript.
loading
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Mutayoba, Beatrice Kemilembe; Ershova, Julia; Lyamuya, Eligius; Hoelscher, Michael; Heinrich, Norbert; Kilale, Andrew Martin; Range, Nyagosya Segere; Ngowi, Benard James; Ntinginya, Nyanda Elias; Mfaume, Saidi Mwinjuma; Nkiligi, Emmanuel; Doulla, Basra; Lyimo, Johnson; Kisonga, Riziki; Kingalu, Amri; Lema, Yakobo; Kondo, Zuwena; Pletschette, Michel.
Afiliação
  • Mutayoba BK; Department of Preventive Services, Ministry of Health National AIDS Control Program, Dodoma, Tanzania.
  • Ershova J; Department of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.
  • Lyamuya E; Division of Global HIV and TB, Global TB Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hoelscher M; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Heinrich N; Department of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.
  • Kilale AM; Department of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.
  • Range NS; Muhimbili Medical Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Ngowi BJ; Muhimbili Medical Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Ntinginya NE; Mbeya College of Health and Allied Sciences, University of Dar es Salaam, Mbeya, Tanzania.
  • Mfaume SM; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Nkiligi E; Muhimbili Medical Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Doulla B; National Tuberculosis and Leprosy Program, Department of Preventive Services, Ministry of Health, Dodoma, Tanzania.
  • Lyimo J; National Tuberculosis and Leprosy Program, Central Tuberculosis Reference Laboratory, Dar es Salaam, Tanzania.
  • Kisonga R; National Tuberculosis and Leprosy Program, Department of Preventive Services, Ministry of Health, Dodoma, Tanzania.
  • Kingalu A; Kibong'oto Infectious Diseases Hospital, Kilimanjaro, Tanzania.
  • Lema Y; National Tuberculosis and Leprosy Program, Department of Preventive Services, Ministry of Health, Dodoma, Tanzania.
  • Kondo Z; Muhimbili Medical Research Centre, National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Pletschette M; National Tuberculosis and Leprosy Program, Department of Preventive Services, Ministry of Health, Dodoma, Tanzania.
Trop Med Int Health ; 27(10): 891-901, 2022 10.
Article em En | MEDLINE | ID: mdl-36089572
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article